Mohsen Jafari
Research Subjects
Mohsen Jafari has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Ali Rastegar-Kashkouli
Kowsar Hospital, Fars Heart Foundation, Research Committee, Shiraz, Iran
10 shared publications - Pourya Yousefi
Kowsar Hospital, Fars Heart Foundation, Research Committee, Shiraz, Iran
10 shared publications - Amir Mohammad Taravati
Nickan Research Institute, Isfahan, Iran
5 shared publications - Dordaneh Rastegar
Nickan Research Institute, Isfahan, Iran
4 shared publications - Mohammad Reza Jafari
Nickan Research Institute, Isfahan, Iran
4 shared publications - Ashkan Khavaran
Faculty of Medicine, University of Freiburg, Freiburg, Germany
2 shared publications
Latest Publications
- Open Access
- 1 July 2024
- Published by Maad Rayan Publishing Company in Journal of Renal Injury Prevention
Predictors of glomerular IgA immunostaining patterns and disease progression in IgA nephropathy patients; a 13-year study of clinical and morphological features of renal biopsies
Introduction: IgA nephropathy (IgAN) is a common primary glomerulonephritis with highly heterogeneous clinical and histopathological features. The MEST-C scoring system has been developed to improve prognostic assessment but lacks elements related to immunostaining study. Objectives: This study aimed to investigate the association between the immunofluorescence (IF) deposits’ patterns of IgA (mesangiocapillary versus pure mesangial) with demographic, clinical, biochemical, and morphological parameters of MEST-C classification in IgAN patients. Patients and Methods: This retrospective, cross-sectional study was conducted on 268 biopsy-proven cases of IgAN from July 2009 to July 2022 at a single laboratory in Isfahan in Iran. The demographic, clinical, and laboratory data including age, gender, serum creatinine, and proteinuria were collected from the biopsy request forms. The morphological parameters of MEST-C classification and IF study patterns were collected from the biopsy reports. Results: The average age of all patients was 37.7 ± 13.47 years, with 67% being males. The mean serum creatinine and proteinuria levels were 1.43 mg/dL and 1730.94 mg/day, respectively. MEST-C score analysis revealed that 171 patients (63.8%) had mesangial expansion (M1), while 105 patients (39.2%) exhibited endocapillary hypercellularity (E1). Additionally, segmental glomerulosclerosis (S1) and tubular atrophy/interstitial fibrosis (T1 and T2) was observed in 160 biopsy samples (59.7%). Moreover, crescent (C) formation was noted in 76 (28.4%) of biopsies. Data analysis using univariate logistic regression demonstrated that E, T, and C on morphology, complement C3, IgG, IgM deposits on IF, and the total MEST score were all associated with an increased risk for mesangiocapillary deposits of IgA. However, using the multivariate method, the results indicated that only the total MEST score (OR: 2.4), presence of crescent (OR: 3.22), presence of endocapillary hypercellularity (OR: 4.86), tubular atrophy/interstitial fibrosis grade II (OR: 34.4), and IgG deposition (OR: 3.37) were independent risk factors for mesangiocapillary deposits of IgA. Conclusion: The total MEST score is significantly higher in mesangiocapillary patterns. Furthermore, the presence of E1, T2, and C1-2 morphological parameters of the updated Oxford classification in renal biopsies are independent risk factors for IgA mesangiocapillary deposits. Hyperactivation of immunoglobulins and the complement system appears to contribute to mesangial-capillary proliferation.
- 1 July 2024
- Published by Maad Rayan Publishing Company in Journal of Renal Injury Prevention
Open AccessPredictors of glomerular IgA immunostaining patterns and disease progression in IgA nephropathy patients; a 13-year study of clinical and morphological features of renal biopsies
Introduction: IgA nephropathy (IgAN) is a common primary glomerulonephritis with highly heterogeneous clinical and histopathological features. The MEST-C scoring system has been developed to improve prognostic assessment but lacks elements related to immunostaining study. Objectives: This study aimed to investigate the association between the immunofluorescence (IF) deposits’ patterns of IgA (mesangiocapillary versus pure mesangial) with demographic, clinical, biochemical, and morphological parameters of MEST-C classification in IgAN patients. Patients and Methods: This retrospective, cross-sectional study was conducted on 268 biopsy-proven cases of IgAN from July 2009 to July 2022 at a single laboratory in Isfahan in Iran. The demographic, clinical, and laboratory data including age, gender, serum creatinine, and proteinuria were collected from the biopsy request forms. The morphological parameters of MEST-C classification and IF study patterns were collected from the biopsy reports. Results: The average age of all patients was 37.7 ± 13.47 years, with 67% being males. The mean serum creatinine and proteinuria levels were 1.43 mg/dL and 1730.94 mg/day, respectively. MEST-C score analysis revealed that 171 patients (63.8%) had mesangial expansion (M1), while 105 patients (39.2%) exhibited endocapillary hypercellularity (E1). Additionally, segmental glomerulosclerosis (S1) and tubular atrophy/interstitial fibrosis (T1 and T2) was observed in 160 biopsy samples (59.7%). Moreover, crescent (C) formation was noted in 76 (28.4%) of biopsies. Data analysis using univariate logistic regression demonstrated that E, T, and C on morphology, complement C3, IgG, IgM deposits on IF, and the total MEST score were all associated with an increased risk for mesangiocapillary deposits of IgA. However, using the multivariate method, the results indicated that only the total MEST score (OR: 2.4), presence of crescent (OR: 3.22), presence of endocapillary hypercellularity (OR: 4.86), tubular atrophy/interstitial fibrosis grade II (OR: 34.4), and IgG deposition (OR: 3.37) were independent risk factors for mesangiocapillary deposits of IgA. Conclusion: The total MEST score is significantly higher in mesangiocapillary patterns. Furthermore, the presence of E1, T2, and C1-2 morphological parameters of the updated Oxford classification in renal biopsies are independent risk factors for IgA mesangiocapillary deposits. Hyperactivation of immunoglobulins and the complement system appears to contribute to mesangial-capillary proliferation.
- Open Access
- 25 May 2024
- Published by Maad Rayan Publishing Company in Journal of Nephropathology
- Vol. 13 (3) , e24547
Thrombotic microangiopathy in IgA nephropathy: pathophysiology, histopathology, and treatment perspectives
The current narrative review study aims to provide an overview of thrombotic microangiopathy (TMA) in immunoglobulin A nephropathy (IgAN), with a particular emphasis on its pathophysiology, histopathology, and treatment options. The prevalence and clinical significance of TMA in IgAN may vary across different populations. Estimates suggest that TMA events occur in 2-50% of patients with IgAN. Endothelial injury is a key factor in TMA development in IgAN, triggered by immune complex deposition, complement activation, and potentially hypertension. TMA in IgAN correlates with vascular lesions, including arterial intimal sclerosis, arteriolar lumen reduction, and smooth muscle hypertrophy. Notably, patients with TMA show more intense deposition of C4, C3d, and C5b-9 complements. Treatment involves blood pressure management, immunosuppression, and targeted therapies such as eculizumab.
- 25 May 2024
- Published by Maad Rayan Publishing Company in Journal of Nephropathology
- Vol. 13 (3) , e24547
Open AccessThrombotic microangiopathy in IgA nephropathy: pathophysiology, histopathology, and treatment perspectives
The current narrative review study aims to provide an overview of thrombotic microangiopathy (TMA) in immunoglobulin A nephropathy (IgAN), with a particular emphasis on its pathophysiology, histopathology, and treatment options. The prevalence and clinical significance of TMA in IgAN may vary across different populations. Estimates suggest that TMA events occur in 2-50% of patients with IgAN. Endothelial injury is a key factor in TMA development in IgAN, triggered by immune complex deposition, complement activation, and potentially hypertension. TMA in IgAN correlates with vascular lesions, including arterial intimal sclerosis, arteriolar lumen reduction, and smooth muscle hypertrophy. Notably, patients with TMA show more intense deposition of C4, C3d, and C5b-9 complements. Treatment involves blood pressure management, immunosuppression, and targeted therapies such as eculizumab.
- Open Access
- 29 January 2024
- Published by Maad Rayan Publishing Company in Journal of Preventive Epidemiology
- Vol. 9 (2) , e35240
Sickle cell nephropathy; exploring epidemiology, diagnostic challenges, and precision medicine advances
Sickle cell nephropathy (SCN) poses an important challenge in the realm of sickle cell disease (SCD) and sickle cell trait (SCT), especially impacting the pediatric population and progressing to chronic kidney disease (CKD) in adulthood. This review navigates through the epidemiology of SCN, emphasizing its variable clinical course and the age-related dynamics of onset. The intricate challenges in diagnosis are explored, highlighting the evolving landscape of early detection and treatment strategies. The prevalence of SCN is intricately linked to the global distribution of SCD and SCT, with higher incidences in regions where these conditions prevail. Diagnosing SCN presents significant challenges due to its variable clinical course, necessitating advanced imaging techniques and novel biomarkers. Promising biomarkers such as KIM-1 and MCP-1 show potential for early detection and intervention, addressing the limitations of conventional diagnostic methods. Precision medicine, focusing on genetic profiling, emerges as a crucial approach for risk stratification and personalized treatment plans. The multifaceted clinical manifestations of SCN, including hematuria, proteinuria, and hypertension, underscore the importance of timely intervention. Treatment strategies involve the administration of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, hydroxyurea for preventing chronic organ damage, and kidney transplantation for end-stage renal disease. Early diagnosis and intervention are critical to mitigate the progression of SCN and its associated complications, emphasizing the need for collaborative efforts in research and precision medicine to improve outcomes for individuals with SCN.
- 29 January 2024
- Published by Maad Rayan Publishing Company in Journal of Preventive Epidemiology
- Vol. 9 (2) , e35240
Open AccessSickle cell nephropathy; exploring epidemiology, diagnostic challenges, and precision medicine advances
Sickle cell nephropathy (SCN) poses an important challenge in the realm of sickle cell disease (SCD) and sickle cell trait (SCT), especially impacting the pediatric population and progressing to chronic kidney disease (CKD) in adulthood. This review navigates through the epidemiology of SCN, emphasizing its variable clinical course and the age-related dynamics of onset. The intricate challenges in diagnosis are explored, highlighting the evolving landscape of early detection and treatment strategies. The prevalence of SCN is intricately linked to the global distribution of SCD and SCT, with higher incidences in regions where these conditions prevail. Diagnosing SCN presents significant challenges due to its variable clinical course, necessitating advanced imaging techniques and novel biomarkers. Promising biomarkers such as KIM-1 and MCP-1 show potential for early detection and intervention, addressing the limitations of conventional diagnostic methods. Precision medicine, focusing on genetic profiling, emerges as a crucial approach for risk stratification and personalized treatment plans. The multifaceted clinical manifestations of SCN, including hematuria, proteinuria, and hypertension, underscore the importance of timely intervention. Treatment strategies involve the administration of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, hydroxyurea for preventing chronic organ damage, and kidney transplantation for end-stage renal disease. Early diagnosis and intervention are critical to mitigate the progression of SCN and its associated complications, emphasizing the need for collaborative efforts in research and precision medicine to improve outcomes for individuals with SCN.
- Open Access
- 29 January 2024
- Published by Maad Rayan Publishing Company in Journal of Renal Injury Prevention
- Vol. 13 (4)
Investigating the potential association between hypertension and cancer: unveiling onco-hypertension as an innovative concept
Hypertension and cancer show a possible association, with hypertension being a result of cancer and its treatments and also serving as a potential risk factor for the development of cancer. The term "onco-hypertension" describes the presence of hypertension in individuals who have been diagnosed with cancer. Among individuals with cancer, hypertension is the most common coexisting medical condition, occurring in 38% of cases. Cancer-related hypertension involves various mechanisms, including tumor-related factors, coexisting conditions, renal dysfunction, hormonal abnormalities, and stress-related inflammation. Cancer treatments like chemotherapy-targeted therapies and immunotherapies have the potential to influence the regulation of blood pressure through the renin-angiotensin-aldosterone system (RAAS), sodium balance, and fluid retention. Epidemiological studies suggest a potential link between hypertension and specific types of cancer, although the exact reasons and underlying mechanisms remain uncertain. Antihypertensive medications have varying associations with cancer risk. Diuretics are linked to renal cell carcinoma (RCC), thiazide medications to squamous cell carcinoma (SCC), and angiotensin-converting enzyme (ACE) inhibitors to a potential increased risk of lung cancer. However, studies on angiotensin receptor blockers (ARBs) show inconclusive results. Managing onco-hypertension may require pharmacological interventions in addition to lifestyle modifications. Antihypertensive medications commonly used include ACE inhibitors, ARBs, diuretics, calcium channel blockers, and beta-blockers. Factors such as overall health, cancer stage, concomitant medications, treatment interactions, efficacy, tolerability, and side effects guide medication selection.
- 29 January 2024
- Published by Maad Rayan Publishing Company in Journal of Renal Injury Prevention
- Vol. 13 (4)
Open AccessInvestigating the potential association between hypertension and cancer: unveiling onco-hypertension as an innovative concept
Hypertension and cancer show a possible association, with hypertension being a result of cancer and its treatments and also serving as a potential risk factor for the development of cancer. The term "onco-hypertension" describes the presence of hypertension in individuals who have been diagnosed with cancer. Among individuals with cancer, hypertension is the most common coexisting medical condition, occurring in 38% of cases. Cancer-related hypertension involves various mechanisms, including tumor-related factors, coexisting conditions, renal dysfunction, hormonal abnormalities, and stress-related inflammation. Cancer treatments like chemotherapy-targeted therapies and immunotherapies have the potential to influence the regulation of blood pressure through the renin-angiotensin-aldosterone system (RAAS), sodium balance, and fluid retention. Epidemiological studies suggest a potential link between hypertension and specific types of cancer, although the exact reasons and underlying mechanisms remain uncertain. Antihypertensive medications have varying associations with cancer risk. Diuretics are linked to renal cell carcinoma (RCC), thiazide medications to squamous cell carcinoma (SCC), and angiotensin-converting enzyme (ACE) inhibitors to a potential increased risk of lung cancer. However, studies on angiotensin receptor blockers (ARBs) show inconclusive results. Managing onco-hypertension may require pharmacological interventions in addition to lifestyle modifications. Antihypertensive medications commonly used include ACE inhibitors, ARBs, diuretics, calcium channel blockers, and beta-blockers. Factors such as overall health, cancer stage, concomitant medications, treatment interactions, efficacy, tolerability, and side effects guide medication selection.
- Open Access
- 1 January 2024
- Published by Maad Rayan Publishing Company in Journal of Renal Endocrinology
- Vol. 10 (1) , e25163
Comparison of four severity-of-disease scores in predicting mortality of trauma patients in ICU; a cross-sectional study
Introduction: Forecasting mortality among trauma patients in the intensive care unit (ICU) is crucial for advancing treatment approaches and elevating the standard of patient care. Objectives: The purpose of this research was to compare well-known severity-of-disease scores in predicting the mortality of trauma patients in the ICU. Materials and Methods: This cross-sectional study was conducted from 2016 to 2017 at the ICU of Amin Hospital, which is affiliated with a university in Isfahan, Iran. Information for calculating the Acute Physiology and Chronic Health Evaluation II (APACHE II), Sequential Organ Failure Assessment (SOFA) score, Injury Severity Score (ISS), and M Score was extracted from patients’ files and compared with their mortality using receiver operating characteristic (ROC) curves. Results: Our study showed that the M Score and SOFA Score have sensitivities of 94.5 and 88.29, and specificities of 88.9 and 80.14, respectively. When comparing the AUC of mean SOFA, mean M Score, APACHE II, and ISS across different age groups and the entire study population, we found that the M Score and SOFA significantly better predict mortality than APACHE II and ISS. Conclusion: This study showed that the M Score and SOFA Score predict the mortality of trauma patients admitted to the ICU better than APACHE II, and that ISS is not appropriate for this task.
- 1 January 2024
- Published by Maad Rayan Publishing Company in Journal of Renal Endocrinology
- Vol. 10 (1) , e25163
Open AccessComparison of four severity-of-disease scores in predicting mortality of trauma patients in ICU; a cross-sectional study
Introduction: Forecasting mortality among trauma patients in the intensive care unit (ICU) is crucial for advancing treatment approaches and elevating the standard of patient care. Objectives: The purpose of this research was to compare well-known severity-of-disease scores in predicting the mortality of trauma patients in the ICU. Materials and Methods: This cross-sectional study was conducted from 2016 to 2017 at the ICU of Amin Hospital, which is affiliated with a university in Isfahan, Iran. Information for calculating the Acute Physiology and Chronic Health Evaluation II (APACHE II), Sequential Organ Failure Assessment (SOFA) score, Injury Severity Score (ISS), and M Score was extracted from patients’ files and compared with their mortality using receiver operating characteristic (ROC) curves. Results: Our study showed that the M Score and SOFA Score have sensitivities of 94.5 and 88.29, and specificities of 88.9 and 80.14, respectively. When comparing the AUC of mean SOFA, mean M Score, APACHE II, and ISS across different age groups and the entire study population, we found that the M Score and SOFA significantly better predict mortality than APACHE II and ISS. Conclusion: This study showed that the M Score and SOFA Score predict the mortality of trauma patients admitted to the ICU better than APACHE II, and that ISS is not appropriate for this task.
- Open Access
- 1 January 2024
- Published by Maad Rayan Publishing Company in Journal of Renal Endocrinology
- Vol. 10 (1) , e25178
Amphetamine-related mortality; a study of postmortem toxicological, pathological, and clinical findings from 2012 to 2022 in Isfahan, Iran
Introduction: Amphetamines represent a widely abused class of drugs globally, with instances of fatalities resulting from inadvertent consumption. Notably, in the year 2008 in Iran, amphetamine emerged as the predominant substance subjected to abuse. Amphetamine induces a spectrum of physiological and psychoactive effects, including heightened arousal, euphoria, diminished fatigue, accelerated heart rate, positive mood, pupil dilation, elevated blood pressure, increased body temperature, behavioral disinhibition, reduced appetite, and heightened alertness. The autopsy and pathological findings associated with fatalities resulting from amphetamine intoxication have garnered limited scrutiny. This study endeavors to characterize and compare the autopsy and pathological findings in amphetamine intoxicated deceased. Objectives: This study aims to investigate and compare the autopsy and pathological findings in cases of amphetamine-related fatalities. It seeks to provide insights into the toxicological, clinical, and pathological profiles of these cases in Isfahan, Iran, over a decade (2012–2022), contributing to a better understanding of the impacts of amphetamine intoxication. Materials and Methods: We systematically identified all instances of amphetamine-related fatalities in Isfahan spanning the period from 2012 to 2022, utilizing data derived from the Noor and Ali Asghar Hospital Electronic Medical Report. Comprehensive information pertaining to demographic characteristics, clinical symptoms, autopsy, and pathology was meticulously documented in a checklist for each patient and subjected to thorough analysis. Results: Between 2012 and 2022, a total of 42 fatalities attributable to amphetamine were identified, encompassing 32 males (76.2%) and 10 females (23.8%), with a mean age of 37.47±10.87 years. Postmortem analyses revealed frequent co-occurrence of tricyclic antidepressants and benzodiazepines in the samples. A notable 14.3% exhibited a history of underlying diseases, while 38.1% had documented psychological disorders. Methamphetamine was the predominant form of the drug, with an average dosage of 3428.7±1618.34 mg. Autopsy findings indicated pulmonary damage in 42.85%, cardiac damage in 23.8%, cerebral damage in 14.28%, hepatic damage in 28.6%, and renal damage in 9.52% of the deceased. Conclusion: Our investigation revealed that amphetamine abuse typically culminates in swift mortality attributed to multi-organ compromise. Amphetamine induces adverse effects encompassing hepatic damage, rhabdomyolysis, pulmonary edema, cerebral edema, and cerebral hemorrhage.
- 1 January 2024
- Published by Maad Rayan Publishing Company in Journal of Renal Endocrinology
- Vol. 10 (1) , e25178
Open AccessAmphetamine-related mortality; a study of postmortem toxicological, pathological, and clinical findings from 2012 to 2022 in Isfahan, Iran
Introduction: Amphetamines represent a widely abused class of drugs globally, with instances of fatalities resulting from inadvertent consumption. Notably, in the year 2008 in Iran, amphetamine emerged as the predominant substance subjected to abuse. Amphetamine induces a spectrum of physiological and psychoactive effects, including heightened arousal, euphoria, diminished fatigue, accelerated heart rate, positive mood, pupil dilation, elevated blood pressure, increased body temperature, behavioral disinhibition, reduced appetite, and heightened alertness. The autopsy and pathological findings associated with fatalities resulting from amphetamine intoxication have garnered limited scrutiny. This study endeavors to characterize and compare the autopsy and pathological findings in amphetamine intoxicated deceased. Objectives: This study aims to investigate and compare the autopsy and pathological findings in cases of amphetamine-related fatalities. It seeks to provide insights into the toxicological, clinical, and pathological profiles of these cases in Isfahan, Iran, over a decade (2012–2022), contributing to a better understanding of the impacts of amphetamine intoxication. Materials and Methods: We systematically identified all instances of amphetamine-related fatalities in Isfahan spanning the period from 2012 to 2022, utilizing data derived from the Noor and Ali Asghar Hospital Electronic Medical Report. Comprehensive information pertaining to demographic characteristics, clinical symptoms, autopsy, and pathology was meticulously documented in a checklist for each patient and subjected to thorough analysis. Results: Between 2012 and 2022, a total of 42 fatalities attributable to amphetamine were identified, encompassing 32 males (76.2%) and 10 females (23.8%), with a mean age of 37.47±10.87 years. Postmortem analyses revealed frequent co-occurrence of tricyclic antidepressants and benzodiazepines in the samples. A notable 14.3% exhibited a history of underlying diseases, while 38.1% had documented psychological disorders. Methamphetamine was the predominant form of the drug, with an average dosage of 3428.7±1618.34 mg. Autopsy findings indicated pulmonary damage in 42.85%, cardiac damage in 23.8%, cerebral damage in 14.28%, hepatic damage in 28.6%, and renal damage in 9.52% of the deceased. Conclusion: Our investigation revealed that amphetamine abuse typically culminates in swift mortality attributed to multi-organ compromise. Amphetamine induces adverse effects encompassing hepatic damage, rhabdomyolysis, pulmonary edema, cerebral edema, and cerebral hemorrhage.
- Open Access
- 3 June 2023
- Published by Maad Rayan Publishing Company in Journal of Nephropharmacology
- Vol. 12 (2) , e10604
Association between type 2 diabetes mellitus and multiple myeloma: Fact or fiction
Multiple myeloma is a plasma cell cancer causing bone and marrow damage, resulting in hypercalcemia, anemia, and renal insufficiency. Diabetes mellitus occurs in 6-24% of multiple myeloma cases, associated with immunosuppression, inflammation, and lymphocyte dysfunction, possibly contributing to multiple myeloma development. Insulin and insulin-like growth factor-1 also contribute to multiple myeloma pathogenesis. The incidence of both multiple myeloma and diabetes mellitus is expected to rise due to the aging population, lifestyle changes, genetic predisposition, and improved diagnostic methods. Although the link between diabetes mellitus and hematological malignancy risk is less conclusive, insulin resistance and growth factors may promote tumor cell proliferation. Genetic variants linked to type 2 diabetes mellitus (T2DM) influence multiple myeloma risks. The insulin like growth factor 1 (IGF1) gene triggers malignant plasma cell proliferation. Additionally, poorly managed T2DM-induced acidosis creates a favorable environment for cancer cell growth, including multiple myeloma. T2DM and metabolic syndrome (MetS) increase multiple myeloma risks through insulin resistance, hyperinsulinemia, inflammation, and dyslipidemia. Inflammatory cytokines [interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-α), and interleukin-1β (IL-1β)] contribute to insulin resistance, chronic inflammation, and multiple myeloma cell survival too. The coexistence of diabetes and multiple myeloma presents challenges in managing complications like neuropathy, nephropathy, and retinopathy. In conclusion, the association between T2DM and multiple myeloma has been established, with a discernible influence from distinct genetic variations. Notably, IL-6, TNF-alpha, and IL-1β exert significant influence on the development of insulin resistance and the proliferation of cancer cells, and also their viability. Consequently, the involvement of inflammatory cytokines, dyslipidemia, and IGF1 in the progression of MM among patients with T2DM and MetS is noteworthy.
- 3 June 2023
- Published by Maad Rayan Publishing Company in Journal of Nephropharmacology
- Vol. 12 (2) , e10604
Open AccessAssociation between type 2 diabetes mellitus and multiple myeloma: Fact or fiction
Multiple myeloma is a plasma cell cancer causing bone and marrow damage, resulting in hypercalcemia, anemia, and renal insufficiency. Diabetes mellitus occurs in 6-24% of multiple myeloma cases, associated with immunosuppression, inflammation, and lymphocyte dysfunction, possibly contributing to multiple myeloma development. Insulin and insulin-like growth factor-1 also contribute to multiple myeloma pathogenesis. The incidence of both multiple myeloma and diabetes mellitus is expected to rise due to the aging population, lifestyle changes, genetic predisposition, and improved diagnostic methods. Although the link between diabetes mellitus and hematological malignancy risk is less conclusive, insulin resistance and growth factors may promote tumor cell proliferation. Genetic variants linked to type 2 diabetes mellitus (T2DM) influence multiple myeloma risks. The insulin like growth factor 1 (IGF1) gene triggers malignant plasma cell proliferation. Additionally, poorly managed T2DM-induced acidosis creates a favorable environment for cancer cell growth, including multiple myeloma. T2DM and metabolic syndrome (MetS) increase multiple myeloma risks through insulin resistance, hyperinsulinemia, inflammation, and dyslipidemia. Inflammatory cytokines [interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-α), and interleukin-1β (IL-1β)] contribute to insulin resistance, chronic inflammation, and multiple myeloma cell survival too. The coexistence of diabetes and multiple myeloma presents challenges in managing complications like neuropathy, nephropathy, and retinopathy. In conclusion, the association between T2DM and multiple myeloma has been established, with a discernible influence from distinct genetic variations. Notably, IL-6, TNF-alpha, and IL-1β exert significant influence on the development of insulin resistance and the proliferation of cancer cells, and also their viability. Consequently, the involvement of inflammatory cytokines, dyslipidemia, and IGF1 in the progression of MM among patients with T2DM and MetS is noteworthy.
- Open Access
- 1 April 2023
- Published by Maad Rayan Publishing Company in Journal of Parathyroid Disease
- Vol. 11 (1) , e11199
Current status and perspectives of ultrasound-guided ablation techniques in patients with primary hyperparathyroidism
Primary hyperparathyroidism (PHPT) is an endocrine disorder characterized by elevated or inappropriately parathormone levels. The most common cause of PHPT is solitary parathyroid adenoma (80-85%). Parathyroid surgery generally encompasses symptomatic PHPT and asymptomatic patients who meet the surgical guideline criteria. If surgery is contraindicated, several non-surgical ablative techniques can be conducted to eliminate the pathological parathyroid tissue, which causes tissue necrosis in the affected gland. This review aims to look into the most recent studies on the efficacy of percutaneous ethanol injection therapy (PEIT), laser ablation (LA), radiofrequency ablation (RFA), microwave ablation (MWA), and high-intensity focused ultrasound (HIFU) in treatment of PHPT and analyze their application prospects. PEIT is a classic method that is less commonly used nowadays. The analysis of thermal ablation methods revealed that LA is inefficient and requires considerable repetition. Meanwhile, the MWA and RFA have a cure rate of over 85% and fewer complications; it seems that they have the potential to replace surgical methods in the future.
- 1 April 2023
- Published by Maad Rayan Publishing Company in Journal of Parathyroid Disease
- Vol. 11 (1) , e11199
Open AccessCurrent status and perspectives of ultrasound-guided ablation techniques in patients with primary hyperparathyroidism
Primary hyperparathyroidism (PHPT) is an endocrine disorder characterized by elevated or inappropriately parathormone levels. The most common cause of PHPT is solitary parathyroid adenoma (80-85%). Parathyroid surgery generally encompasses symptomatic PHPT and asymptomatic patients who meet the surgical guideline criteria. If surgery is contraindicated, several non-surgical ablative techniques can be conducted to eliminate the pathological parathyroid tissue, which causes tissue necrosis in the affected gland. This review aims to look into the most recent studies on the efficacy of percutaneous ethanol injection therapy (PEIT), laser ablation (LA), radiofrequency ablation (RFA), microwave ablation (MWA), and high-intensity focused ultrasound (HIFU) in treatment of PHPT and analyze their application prospects. PEIT is a classic method that is less commonly used nowadays. The analysis of thermal ablation methods revealed that LA is inefficient and requires considerable repetition. Meanwhile, the MWA and RFA have a cure rate of over 85% and fewer complications; it seems that they have the potential to replace surgical methods in the future.
- Open Access
- 1 January 2023
- Published by Maad Rayan Publishing Company in Journal of Renal Endocrinology
- Vol. 9 (1) , e25092
Herbal medicine in the management of renal disease: A comprehensive review of its potential for acute kidney injury, chronic kidney disease, diabetic nephropathy, and hypertension
Each year, a considerable number of individuals are diagnosed with potentially life-threatening renal failure, encompassing acute kidney injury (AKI) and chronic kidney disease (CKD). New natural herbal compounds, whether used in isolation or combined with medical treatments and an appropriate regime, have been suggested for the management of renal failure. The etiology of AKI remains uncertain; nevertheless, several factors have been proposed as potential causative agents that can lead to renal failure, including renal ischemia-reperfusion injury (IRI), nephrotoxicity, sepsis, administration of radiocontrast agents, and exposure to heavy metal ions. Several commonly utilized herbs with anti-diabetic and antihypertensive properties, known for their antioxidant, anti-inflammatory, and vasorelaxant effects, have been recognized as efficacious therapeutic agents in the management of CKD. The management of renal failure typically involves treating the underlying diseases, such as IRI, sepsis, and diabetes. However, if addressing the root cause is not possible, the focus shifts to managing complications like hypertension and proteinuria.
- 1 January 2023
- Published by Maad Rayan Publishing Company in Journal of Renal Endocrinology
- Vol. 9 (1) , e25092
Open AccessHerbal medicine in the management of renal disease: A comprehensive review of its potential for acute kidney injury, chronic kidney disease, diabetic nephropathy, and hypertension
Each year, a considerable number of individuals are diagnosed with potentially life-threatening renal failure, encompassing acute kidney injury (AKI) and chronic kidney disease (CKD). New natural herbal compounds, whether used in isolation or combined with medical treatments and an appropriate regime, have been suggested for the management of renal failure. The etiology of AKI remains uncertain; nevertheless, several factors have been proposed as potential causative agents that can lead to renal failure, including renal ischemia-reperfusion injury (IRI), nephrotoxicity, sepsis, administration of radiocontrast agents, and exposure to heavy metal ions. Several commonly utilized herbs with anti-diabetic and antihypertensive properties, known for their antioxidant, anti-inflammatory, and vasorelaxant effects, have been recognized as efficacious therapeutic agents in the management of CKD. The management of renal failure typically involves treating the underlying diseases, such as IRI, sepsis, and diabetes. However, if addressing the root cause is not possible, the focus shifts to managing complications like hypertension and proteinuria.
- Open Access
- 1 January 2022
- Published by Maad Rayan Publishing Company in Journal of Renal Endocrinology
- Vol. 8 (1) , e25064
Effects of gender on the efficacy and response to COVID-19 vaccination; a review study on current knowledge
Vaccination is one of the most important public health strategies to reduce mortality and morbidity of various infectious diseases. The COVID-19 pandemic was declared, on March 11, 2020, since then, the virus has spread rapidly, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines have played the main substantial role in advancing the management of the COVID-19 pandemic. As is well known, sex/gender-related differences affect vaccine efficacy, response, and acceptability. This review aims to compare the effects of sexual dimorphism and gender-related differences factors on the efficacy, responses, and acceptance of the COVID-19 vaccines. As far as the COVID-19 vaccine effectiveness is concerned, both males and females with the COVID-19 vaccine showed consistent and impressive efficacy; although males showed slightly greater efficacy, there was no significant correlation between the efficacy of the COVID-19 vaccine and their sex or gender differences. Consequently, to reduce adverse reactions in females, sex differences should be considered in the design of the COVID-19 vaccine. It is also essential to conduct pragmatic trials to verify whether sex differences in vaccine response and efficacy vary with age.
- 1 January 2022
- Published by Maad Rayan Publishing Company in Journal of Renal Endocrinology
- Vol. 8 (1) , e25064
Open AccessEffects of gender on the efficacy and response to COVID-19 vaccination; a review study on current knowledge
Vaccination is one of the most important public health strategies to reduce mortality and morbidity of various infectious diseases. The COVID-19 pandemic was declared, on March 11, 2020, since then, the virus has spread rapidly, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines have played the main substantial role in advancing the management of the COVID-19 pandemic. As is well known, sex/gender-related differences affect vaccine efficacy, response, and acceptability. This review aims to compare the effects of sexual dimorphism and gender-related differences factors on the efficacy, responses, and acceptance of the COVID-19 vaccines. As far as the COVID-19 vaccine effectiveness is concerned, both males and females with the COVID-19 vaccine showed consistent and impressive efficacy; although males showed slightly greater efficacy, there was no significant correlation between the efficacy of the COVID-19 vaccine and their sex or gender differences. Consequently, to reduce adverse reactions in females, sex differences should be considered in the design of the COVID-19 vaccine. It is also essential to conduct pragmatic trials to verify whether sex differences in vaccine response and efficacy vary with age.